Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Brainstorm Cell TherapeuticsGamida CellX4 PharmaceuticalsAxcella HealthErytech Pharma
SymbolNASDAQ:BCLINASDAQ:GMDANASDAQ:XFORNASDAQ:AXLANASDAQ:ERYP
Price Information
Current Price$4.90$3.25$8.30$2.61$4.79
52 Week RangeBuyBuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$9.00$17.50$21.43$22.00$13.00
% Upside from Price Target83.67% upside438.46% upside158.18% upside742.91% upside171.40% upside
Trade Information
Market Cap$128.53 million$77.75 million$146.66 million$68.88 million$85.93 million
Beta0.341.210.86N/A1.99
Average Volume761,30133,68496,08842,7401,706
Sales & Book Value
Annual RevenueN/AN/AN/AN/AN/A
Price / SalesN/AN/AN/AN/AN/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value($0.54) per share$1.44 per share$10.37 per shareN/A$5.34 per share
Price / BookN/AN/AN/AN/AN/A
Profitability
Net Income$-23,250,000.00$-34,350,000.00$-52,810,000.00$-36,070,000.00$-70,180,000.00
EPS($1.06)($1.69)($4.63)($3.55)($3.92)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/A∞N/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)-684.41%-169.58%-58.46%-367.32%N/A
Return on Assets (ROA)-265.29%-75.82%-41.87%-59.50%N/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.12%0.17%0.41%0.15%
Current Ratio0.19%4.98%13.69%11.19%4.10%
Quick Ratio0.19%4.98%13.68%11.75%4.09%
Ownership Information
Institutional Ownership Percentage7.90%22.74%68.51%63.27%7.44%
Insider Ownership Percentage21.20%N/A4.90%N/AN/A
Miscellaneous
Employees3170N/AN/A172
Shares Outstanding26.23 million24.22 million16.13 million23.11 million17.94 million
Next Earnings Date5/8/2020 (Estimated)5/5/2020 (Estimated)5/20/2020 (Estimated)6/18/2020 (Estimated)N/A
OptionableOptionableNot OptionableNot OptionableNot OptionableNot Optionable
Comparison Ideas:
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel